All News about Sigyn Therapeutics Inc
Via NewMediaWire
Topics
Regulatory Compliance
Sigyn Therapeutics Announces Third Quarter 2022 Financial Results
November 15, 2022
Via NewMediaWire
Topics
Intellectual Property
Exposures
Intellectual Property
Sigyn Therapeutics Announces First-In-Human Clinical Strategy to Address Inflammation and Endotoxemia in End-Stage Renal Disease Patients
September 14, 2022
Via NewMediaWire
Topics
Death
Exposures
Death
Sigyn Therapeutics Appoints Alexander S. Yevzlin, MD, FASN to Its Scientific Advisory Board
March 09, 2022
Via NewMediaWire
Topics
Death
Exposures
Death
Sigyn Therapeutics Reports the Successful Completion of a Study to Address Gram-Positive Bacterial Toxins Associated with Sepsis
December 01, 2021
Via NewMediaWire
Topics
Death
Exposures
Death
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.